Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn's disease.

Abstract

Azathioprine is widely used for the treatment of Crohn's disease (CD). Few cases from Western countries have reported idiopathic non-cirrhotic portal hypertension (NCPH) related to thiopurine therapy in patients with inflammatory bowel disease. Idiopathic NCPH is a rare hepatic condition with intrahepatic portal hypertension but no evidence of cirrhosis or chronic liver disease. Patients with idiopathic NCPH present with symptoms of portal hypertension such as thrombocytopenia, splenomegaly and esophageal varices. We report a case of idiopathic NCPH in a 51-year-old male patient with CD who had been taking azathioprine for 5 years. He was admitted due to esophageal variceal bleeding along with splenomegaly and thrombocytopenia. Evaluation of cirrhosis or chronic liver disease showed normal-range results as estimated by FibroScan evaluation, laboratory examination for autoimmune hepatitis or viral hepatitis, and liver biopsy. This case may suggest the need for careful monitoring for manifestations of portal hypertension in Asian patients with inflammatory bowel disease receiving thiopurine treatment.

• Authors: Jong Won Seo, Eun Soo Kim, Man-Hoon Han, Young Oh Kweon
• Journal: Intestinal research (Intest Res) Vol. 19 Issue 2 Pg. 247-251 (Apr 2021) ISSN: 1598-9100 [Print] Korea (South)
• PMID: 32610890 (Publication Type: Case Reports)